{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:31:48Z","timestamp":1792233108726,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jchromb.2022.123493","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T09:16:38Z","timestamp":1665652598000},"page":"123493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Quantification of vancomycin and clindamycin in human plasma and synovial fluid applying ultra-performance liquid chromatography tandem mass spectrometry"],"prefix":"10.1016","volume":"1212","author":[{"given":"L.T.","family":"Ringeling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bahmany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Oldenrijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Veltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2022.123493_b0005","first-page":"347","article-title":"Periprosthetic infection in joint replacement - Diagnosis and treatment","volume":"114","author":"Otto-Lambertz","year":"2017","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jchromb.2022.123493_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.jchromb.2022.123493_b0015","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-018-0622-0","article-title":"Prosthetic Joint Infections: an Update","volume":"20","author":"Abad","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.jchromb.2022.123493_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cger.2010.04.002","article-title":"Total joint replacement in the elderly patient","volume":"26","author":"Talmo","year":"2010","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.jchromb.2022.123493_b0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1302\/2058-5241.4.180092","article-title":"Periprosthetic joint infection: current concepts and outlook","volume":"4","author":"Izakovicova","year":"2019","journal-title":"EFORT Open Rev."},{"key":"10.1016\/j.jchromb.2022.123493_b0030","doi-asserted-by":"crossref","unstructured":"F. Landersdorfer, C.B., Bulitta, J.B., Nation, R.L., & S\u00f6rgel, Pharmacokinetics and Pharmacodynamics of Antibiotics in Bone, John Wiley & Sons, Inc., 2015. 10.1002\/9781119720676.ch6.","DOI":"10.1002\/9781118581742.ch3"},{"key":"10.1016\/j.jchromb.2022.123493_b0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jchromb.2022.123493_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2020.01.080","article-title":"Is Treatment of Periprosthetic Joint Infection Improving Over Time?","volume":"35","author":"Xu","year":"2020","journal-title":"J. Arthroplasty."},{"key":"10.1016\/j.jchromb.2022.123493_b0045","first-page":"184","article-title":"Antibiotic-loaded bone cement in total joint arthroplasty","volume":"81","author":"Soares","year":"2015","journal-title":"Acta Orthop. Belg."},{"key":"10.1016\/j.jchromb.2022.123493_b0050","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9872.1000196","article-title":"Determination of Vancomycin in Human Plasma, Bone and Fat by Liquid Chromatography\/Tandem Mass Spectrometry","volume":"5","author":"Zhang","year":"2014","journal-title":"J. Anal. Bioanal. Tech."},{"key":"10.1016\/j.jchromb.2022.123493_b0055","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2013-0142","article-title":"Quantification of vancomycin in human serum by LC-MS\/MS","volume":"51","author":"K\u00f6nig","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2022.123493_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112939","article-title":"A novel method for the determination of vancomycin in serum by high-performance liquid chromatography-tandem mass spectrometry and its application in patients with diabetic foot infections","volume":"23","author":"Liu","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.jchromb.2022.123493_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.887","article-title":"Quantitative analysis of clindamycin in human plasma by liquid chromatography\/electrospray ionisation tandem mass spectrometry using d1-N-ethylclindamycin as internal standard","volume":"17","author":"Rechberger","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2022.123493_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-4347(99)00018-3","article-title":"Determination of clindamycin in human plasma by liquid chromatography-electrospray tandem mass spectrometry: Application to the bioequivalence study of clindamycin","volume":"724","author":"Yu","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2022.123493_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-4347(01)00060-3","article-title":"Sensitive and specific determination of clindamycin in human serum and bone tissue applying liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry","volume":"755","author":"Martens-Lobenhoffer","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2022.123493_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2018.02.005","article-title":"Sensitive analytical method to quantify clindamycin in plasma and microdialysate samples: Application in a preclinical pharmacokinetic study","volume":"153","author":"Girondi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123493_b0085","unstructured":"US Department of Health and Human Services, Guidance for Industry, Bioanalytical Method Validation, (2001). https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (accessed November 5, 2021)."},{"key":"10.1016\/j.jchromb.2022.123493_b0090","unstructured":"European Medicines Agency, EMA: Guideline of Bioanalytical method validation, (2011). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf (accessed November 5, 2021)."},{"key":"10.1016\/j.jchromb.2022.123493_b0095","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2022.123493_b0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/2047-783X-15-12-533","article-title":"Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin","volume":"15","author":"Estes","year":"2010","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jchromb.2022.123493_b0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1469-0691.12071","article-title":"Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study","volume":"19","author":"Dub\u00e9e","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jchromb.2022.123493_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-015-0773-y","article-title":"Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections","volume":"43","author":"Curis","year":"2015","journal-title":"Infection."},{"key":"10.1016\/j.jchromb.2022.123493_b0115","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s11999-011-1937-4","article-title":"Sufficient Release of Antibiotic by a Spacer 6 Weeks after Implantation in Two-stage Revision of Infected Hip Prostheses","volume":"469","author":"Fink","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jchromb.2022.123493_b0120","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1302\/0301-620X.87B6.15411","article-title":"Treatment of deep infection of the hip associated with massive bone loss","volume":"87-B","author":"Hsieh","year":"2005","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.jchromb.2022.123493_b0125","article-title":"From manual microscopy to automated cell counters for first line screening of body fluids: \u201cBut not without a special body fluid mode\u201d","volume":"41","author":"Fleming","year":"2016","journal-title":"Ned. Tijdschr. Voor Klin. Chemie En Lab."},{"key":"10.1016\/j.jchromb.2022.123493_b0130","doi-asserted-by":"crossref","DOI":"10.1021\/pr500587x","article-title":"A normative study of the synovial fluid proteome from healthy porcine knee joints","volume":"13","author":"Bennike","year":"2014","journal-title":"J. Proteome Res."},{"issue":"8","key":"10.1016\/j.jchromb.2022.123493_b0135","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/CORR.0000000000001188","article-title":"Synovial Fluid Aspirates Diluted with Saline or Blood Reduce the Sensitivity of Traditional and Contemporary Synovial Fluid Biomarkers","volume":"478","author":"Deirmengian","year":"2020","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jchromb.2022.123493_b0140","unstructured":"European Committee on Antimicrobial Susceptibility Testing, EUCAST: Clinical breakpoints and dosing of antibiotics, (n.d.). https:\/\/eucast.org\/clinical_ breakpoints\/ (accessed February 8, 2022)."},{"key":"10.1016\/j.jchromb.2022.123493_b0145","first-page":"221","article-title":"Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty","volume":"14","author":"Eshkenazi","year":"2001","journal-title":"Am. J. Knee Surg."},{"key":"10.1016\/j.jchromb.2022.123493_b0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.arth.2013.08.017","article-title":"Vancomycin Concentration in Synovial Fluid: Direct Injection into the Knee vs. Intravenous Infusion","volume":"29","author":"Roy","year":"2014","journal-title":"J. Arthroplasty."},{"key":"10.1016\/j.jchromb.2022.123493_b0155","doi-asserted-by":"crossref","unstructured":"R.C. Moellering, D.J. Krogstad, D.J. Greenblatt, Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function., Rev. Infect. Dis. 3 suppl (n.d.) S230-5.","DOI":"10.1093\/clinids\/3.Supplement_2.S230"},{"key":"10.1016\/j.jchromb.2022.123493_b0160","doi-asserted-by":"crossref","unstructured":"M.A. Plott, H. Roth, Penetration of clindamycin into synovial fluid., Clin. Pharmacol. Ther. 11 (n.d.) 577\u2013580. 10.1002\/cpt1970114577.","DOI":"10.1002\/cpt1970114577"},{"key":"10.1016\/j.jchromb.2022.123493_b0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1185\/03007997209111153","article-title":"Penetration of lincomycin ('Lincocin\u2019) and clindamycin ('Dalacin C\u2019) into the synovial cavity in rheumatoid arthritis","volume":"1","author":"Deodhar","year":"1972","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jchromb.2022.123493_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/mas.20298","article-title":"An overview of matrix effects in liquid chromatography-mass spectrometry","volume":"30","author":"Trufelli","year":"2011","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jchromb.2022.123493_b0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpba.2013.11.004","article-title":"Simultaneous analysis of antibiotics in biological samples by ultra high performance liquid chromatography-tandem mass spectrometry","volume":"89","author":"Cazorla-Reyes","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123493_b0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin. Pharmacokinet."},{"issue":"Suppl 1","key":"10.1016\/j.jchromb.2022.123493_b0185","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2022.123493_b0190","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/jac\/dks066","article-title":"Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years","volume":"67","author":"Grace","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jchromb.2022.123493_b0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.1875-9114.1992.tb02671.x","article-title":"Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations","volume":"12","author":"Kays","year":"1992","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.jchromb.2022.123493_b0200","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01433-10","article-title":"Protein binding: Do we ever learn?","volume":"55","author":"Zeitlinger","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2022.123493_b0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF00716386","article-title":"Serum and plasma concentrations of clindamycin following a single intramuscular injection of clindamycin phosphate in maintenance haemodialysis patients and normal subjects","volume":"14","author":"Roberts","year":"1978","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123493_b0210","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003086-197509000-00019","article-title":"Antibiotic bone penetration. Concentrations of methicillin and clindamycin phosphate in human bone taken during total hip replacement","volume":"111","author":"Schurman","year":"1975","journal-title":"Clin. Orthop. Relat. Res."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322200397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322200397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:09:50Z","timestamp":1761606590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322200397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":42,"alternative-id":["S157002322200397X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123493","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of vancomycin and clindamycin in human plasma and synovial fluid applying ultra-performance liquid chromatography tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123493"}}